Clinical Trials · NCT02129985
Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapy
- Phase
- Phase 4
- Recruitment status
- Unknown
- Sponsor
- xiaolong zhao
- Enrollment
- 100
- Start date
- Feb 2014
- Locations
- 1 site, China
- Primary endpoint
- time to glycaemic remission